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The macromolecular machines of life use allosteric control to self-assemble, dissociate and
change shape in response to signals. Despite enormous interest, the design of nanoscale
allosteric assemblies has proven tremendously challenging. Here we present a proof of
concept of allosteric assembly in which an engineered fold switch on the protein monomer
triggers or blocks assembly. Our design is based on the hyper-stable, naturally monomeric
protein CI2, a paradigm of simple two-state folding, and the toroidal arrangement with 6-fold
symmetry that it only adopts in crystalline form. We engineer CI2 to enable a switch between
the native and an alternate, latent fold that self-assembles onto hexagonal toroidal particles
by exposing a favorable inter-monomer interface. The assembly is controlled on demand via
the competing effects of temperature and a designed short peptide. These ﬁndings unveil a
remarkable potential for structural metamorphosis in proteins and demonstrate key principles
for engineering protein-based nanomachinery.
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The molecular machinery in charge of all biological pro-cesses is based on protein assemblies1. Such nanoscalemachines perform sophisticated functions by exploiting the
ability of proteins to use thermal, and occasionally chemical,
energy to interact and change shape in response to speciﬁc sti-
muli2. Accordingly, a large percentage of the proteome consists of
proteins that form macromolecular complexes in their functional
state3. The catalog of biological assemblies is, however, limited in
variety and highly conserved through evolution4. Learning how to
design and engineer protein assemblies and understanding their
modes of operation is thus of enormous interest.
The engineering of protein assemblies has become a major
research thrust, with recent developments breaking new
ground5. The most direct approach builds assemblies based on
protein–protein interaction domains that already exist in nat-
ure6. In early implementations, redesigning the leucine-zipper
motif permitted to obtain α-helical coiled-coil complexes con-
taining up to seven monomers7. Larger assemblies that organize
into nanoscale objects such as ﬁlaments, cages, or layers have
been later achieved by joining together various oligomerization
domains8–10. Building assemblies from globular proteins that
are naturally monomeric is more challenging. In this regard, it
has been noted that the crystal lattice from X-ray structures
hints at the preferred packing symmetry and potential interac-
tion interface between monomers11,12. Once the assembly
interface is identiﬁed from the crystal, computational optimi-
zation of the interface can lead to designed protein sequences
that form stable assemblies13–15. Most recently, a hybrid
approach that combines existing oligomerization domains and
in silico optimization has rendered spectacular results, produ-
cing tetrahedral and icosahedral cages16,17, which can be func-
tionalized by gene fusion to form encapsulated protein
nanoscale cages that mimic virus assembly18.
In addition to static rigid assemblies, major strides have been
made in the last years in engineering dynamic protein arrange-
ments that incorporate mechanisms to control the assembly
process and/or the stoichiometry19,20. The engineering of metal
coordination motifs21,22, bivalent drug binding23, and disulﬁde
bonds24 onto various protein scaffolds have been used as strate-
gies to enable templated assembly of protein monomers in ways
that respond to external cues. Scientists have exploited these
strategies to produce protein assemblies that grow in one
dimension to make nanowires23 and nanotubes21 that can self-
close to form nanorings25, or that grow in two and three
dimensions leading to various crystalline arrangements21,26. One
advantage of templated assembly is its generalizability to virtually
any protein scaffold using straightforward protein engineering
tools, including the possibility of reverse engineering natural
protein assemblies27. The main advantage is, of course, that the
assembly process becomes controllable by an external cue, for
example, the concentration of a bivalent drug23, or even multiple
cues, such as metal concentration, pH and chelators21,22, or metal
identity, redox potential, and mechanical stress28. The combina-
tion of two of these mechanisms leads to even more sophisticated
behavior, such as the re-creation of an allosteric transition by
introducing structural strain between metal binding and disulﬁde
bond formation on a designed protein tetramer29,30.
These strategies are captivating, but still engineer proteins as
modular building blocks without taking full advantage of their
ability to experience conformational transitions that drastically
change their functional properties (binding, assembly, catalysis)
in response to stimuli. Here we tackle this challenge by intro-
ducing an approach to build allosteric protein complexes in
which the assembly–disassembly process is controlled externally
through an engineered fold switch. We start by deﬁning the
symmetry and stoichiometry of assembly from the crystal lattice
arrangement of the monomeric protein, thereby extending an
approach used before to design dimer interfaces on globular
proteins13. To implement allosteric control, we aim at thermo-
dynamically coupling the assembly process to a fold-switch
transition in the monomer (Fig. 1). Fold switching is a relatively
recently discovered phenomenon in which a “metamorphic”
protein alternates between two different folds31–33. Metamorphic
proteins play complex regulatory roles34, such as the ticking
mechanism of circadian clocks35. The key to this approach is that
assembly occurs via the oligomerization of an alternate fold,
which exposes a potential assembly interface that is hidden in the
native structure. The exposure/burial of oligomerization inter-
faces upon fold switching is common to metamorphic pro-
teins32,35,36. From an engineering viewpoint, we note that the
alternate fold must be metastable in the monomer, so that
assembly can be blocked or triggered on cue by controlling the
stability of the native ground state (e.g., by temperature, coun-
terions, binding to an effector) and/or protein concentration. On
these conditions, the alternate fold will operate as an allosteric
switch for assembly37,38.
Results
A protein scaffold for building allosteric assemblies. As scaffold
for implementing fold-switched allosteric assemblies, we chose
chymotrypsin inhibitor 2 (CI2) from barley seeds. At ﬁrst glance,
CI2 seems an unseemly election. The small (<70 residues) glob-
ular single-domain CI2 is a paradigm of two-state folding in
which a sturdy native structure unfolds at an extremely slow rate
via an all-or-none transition39. In solution, we ﬁnd that CI2 is
monomeric at concentrations up to the millimolar range (Sup-
plementary Fig. 1) and remains monomeric even after unfolding
partially at high temperatures (Supplementary Fig. 2). There are,
however, structural hints of metamorphic potential. The CI2
native structure contains a four-stranded β-sheet and one α-helix
connecting strands 1 and 2 (Fig. 2a). The C-terminal β-strand is
inserted in antiparallel fashion into the sheet’s middle, breaking
an otherwise parallel arrangement to form a unique fold that is
speciﬁc to this family of serine protease inhibitors (Supplemen-
tary Fig. 3). It is of note that removal of that last strand (dark blue
in Fig. 2a) would transform the CI2 topology onto an elementary
Rossmann fold, which is one of the most common natural protein
architectures40. Sequence conservation among CI2 orthologs also
unveils evolutionary pressure to keep the C-terminal β-strand
inserted, including the addition of a disulﬁde crosslink in the sub-
family of trypsin inhibitors (Fig. 2a, Supplementary Fig. 3).
To identify possible spatial arrangements for assembly, we
analyzed the crystal lattice of CI2 by X-ray crystallography. CI2
crystallizes in the hexagonal space group P622 in all the
conditions we attempted that rendered crystals (Table 1 and
Supplementary Table 1). On the lattice, the protein forms double
hexameric rings in which the two rings are packed head to head
and rotated by ~30° (Fig. 2b). This spatial arrangement is strongly
predeﬁned by symmetry, and thus we identify the toroidal D6
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Fig. 1 Fold-switch mechanism for allosteric assembly. The general
thermodynamic scheme to introduce allosteric control of assembly is based
on thermodynamically coupling a metamorphic transition in the monomer
to the assembly process.
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particles of the crystal as the target for engineering a CI2
assembly. The lattice also reveals that inter-monomer contacts are
few and feeble, both between ring neighbors (Fig. 2c) and across
rings (Fig. 2d, left), explaining why the protein is monomeric at
all conditions outside the crystal (see also Supplementary Fig. 4).
An unexpected discovery was that we observed domain swapping
at certain crystallization conditions. Indeed, crystals obtained
using salt as primary precipitant (Supplementary Table 1) follow
the standard arrangement of early structural work on CI241
(Fig. 2d, left), whereas crystals grown with PEG feature domain-
swapped dimers arranged in the same lattice structure and group
symmetry (Fig. 2d, right). In domain-swapped crystals, equivalent
monomers on the two rings exchange their C-terminal segments
(residues 39–66; see Fig. 2a) to form dimers that covalently link
the rings via the active loops (Fig. 2d, right). Domain swapping
does not affect the monomer–monomer interface of each ring,
and thus is unable to self-sufﬁciently promote assembly in
solution, but it does demonstrate an inherent tendency of the C
terminus of CI2 to unwind, and the robustness of the toroidal D6
packing symmetry for this protein.
Engineering CI2 to fold switch and oligomerize. Rather than
optimizing the weak inter-monomer contacts of the crystal lattice
(Fig. 1c, Supplementary Fig. 4), which would just produce a rigid
assembly, we targeted the monomer conformational properties
aiming to drive assembly via a fold switch. This strategy is
inspired by naturally metamorphic proteins, in which one of the
alternate folds often exposes a sticky interface for oligomeriza-
tion31,42,43. One key to fold switching is for the monomeric fold
to be on the brink of stability so that the metastable, assembly-
prone fold can eventually compete42. Inspired by previous
attempts to design fold switchers44,45, we targeted speciﬁc CI2
residues that are away from the inter-monomer interface of the
crystal (Fig. 2c), participate in deﬁning the native topology
(particularly in keeping the antiparallel last strand inserted
between strands 1 and 3, see Fig. 2a), but are not highly conserved
within the family of serine protease inhibitors (Supplementary
Fig. 3). We selected 10 such locations scattered throughout the
CI2 sequence and designed mutations on them that: (1) are
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Fig. 2 Engineering CI2 to promote fold switching and assembly. a The native-fold topology of CI2 highlighting the C-terminal antiparallel β-strand (dark
blue), highly conserved residues (red), native backbone hydrogen bonds (black dashed lines), the disulﬁde bond of trypsin inhibitors (orange), and the
domain-swapped segment (medium-shade blue). b Top view of the double hexameric arrangement that CI2 adopts in the crystal lattice (6QIY). c Inter-
monomer interactions that stabilize the rings in the crystal. d (Left) side view of the double-ring and stereo view of equivalent monomers from top and
bottom rings in the standard structure (6QIY). (Right) as in left for the domain-swapped structure (6QIZ). The omit electron density map contoured at
3.0σ is shown for the I39 to E43 segment (sticks). e Mutations used to engineer CI2: (red) wild-type side chain and (blue) replaced side chain.
f Comparison between the wild-type NMR structure (3CI2.PDB, red) and the structure of monomeric CI2eng obtained from experimental chemical shifts
and CS-Rosetta (blue). g Equilibrium and h kinetics as a function of chemical denaturant for CI2 (red) and CI2eng (blue).
Table 1 Data collection and reﬁnement statistics.
Classical geometry
(condition a)
Domain swapping
(condition b)
Data collection
Space group P622 P622
Cell dimensions
a, b, c (Å) 68.77, 68.77, 50.56 68.55, 68.55, 53.10
α, β, γ (°) 90, 90, 120 90, 90, 120
Resolution (Å) 34.39–1.50 (1.55–1.50) 39.58–1.65 (1.71–1.65)
Rmerge 0.059 (2.059) 0.083 (1.195)
I /σI 23.00 (1.80) 15.20 (1.60)
Completeness (%) 99.50 (99.65) 99.84 (99.23)
Redundancy 18.1 (18.3) 8.3 (8.3)
Reﬁnement
Resolution (Å) 34.39–1.50 (1.55–1.50) 39.58–1.65 (1.71–1.65)
No. of reﬂections 11,750 (1143) 9305 (903)
Rwork/Rfree 0.21 (0.35)/
0.26 (0.37)
0.18 (0.27)/
0.22 (0.34)
No. of atoms
Protein 527 529
Ligand/ion – –
Water 65 97
B-factors
Protein 37.53 26.38
Ligand/ion – –
Water 43.44 37.83
R.m.s. deviations
Bond lengths (Å) 0.006 0.006
Bond angles (°) 0.86 0.86
Values within parentheses are for highest-resolution shell
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conservative in both structure and sequence; (2) increase the
intrinsic propensity to form the native secondary structure ele-
ments (minimize folding cooperativity46); and (3) scramble the
packing of the two native hydrophobic mini-cores while they
maintain the overall hydrophobicity of the protein. The ﬁnal set
of designed mutations is shown on the CI2 structure in Fig. 2e.
Further mutational details are given in Supplementary Table 2
and the Methods section. We then produced a suitably engi-
neered CI2 version (CI2eng) as the basis for our study. To
investigate the structural properties of the CI2eng monomer, we
used multidimensional nuclear magnetic resonance (NMR) on a
15N-13C isotopically labeled sample. From the chemical shifts, we
obtained a three-dimensional (3D) structure employing CS-
Rosetta47, which shows that the engineered monomer conserves
the native fold (Fig. 2f). CI2eng also maintains biological activity,
as shown on enzymatic inhibition assays (Supplementary Fig. 5).
Equilibrium and kinetic chemical denaturation experiments
reveal that the native fold of CI2eng has basal stability (Fig. 2g, h),
thus meeting our ﬁrst design criterion. Moreover, the induced
destabilization arises from a highly accelerated unfolding rate
(~300-fold) without signiﬁcant slowdown of the folding rate
(Fig. 2h). A much faster unfolding rate meets a second design
criterion by facilitating the opening of the native structure that is
required to enable fold switching42.
Formation of toroidal assemblies in solution. Size-exclusion
chromatography of CI2eng at concentrations above those used for
the previous folding studies revealed speciﬁc oligomerization
consistent with a mixture of single (H) and double (H2) hexamers
in addition to the monomer (M) (Fig. 3a). Combining size-
exclusion chromatography and multi-angle light scattering, we
could determine a molecular mass of ~7 kDa for the monomer
peak, and a mixture of two species with masses of ~44 kDa
(consistent with H) and ~88 kDa (consistent with H2) for the
polydisperse peak (Supplementary Fig. 6). Further analysis of
sedimentation velocities, determined by analytical ultra-
centrifugation at different concentrations, fully resolves the two
complexes with sedimentation coefﬁcients consistent with H and
H2 particles (Fig. 3b). Both methods show the populations of M,
H, and H2 changing with protein concentration, as expected for a
dynamic equilibrium between monomer and assembly (Supple-
mentary Fig. 7).
To determine the structural properties in solution of the CI2eng
self-assembled particles, we used electron microscopy (EM) (see
Methods). We ﬁrst carried out standard negative staining analysis
(Supplementary Fig. 8), which showed large populations of ring-
like structures. The ring particles have size consistent with the
expectation for negatively stained double hexamers (12 × 7 kDa)
and a distinct 6-fold symmetry equivalent to that found in the
wild-type crystal lattice. Subsequently, we performed cryo-
electron microscopy (cryo-EM) to derive a structural model of
the assembled particle without ﬁxation and staining. Figure 2c
shows a cryo-EM image of a vitriﬁed CI2eng sample taken at
120,000 × magniﬁcation that highlights the <100 Å particles
(near the size limit for cryo-EM) that CI2eng forms in solution.
The two most common particle views have either doughnut-like
shape with distinct 6-fold symmetry or roughly rectangular
shape (arrows and arrowheads in Fig. 3c, respectively). These
shapes are consistent with top and side projections of a double
hexameric toroid (see 2D classes in Fig. 3c). Large-scale data
acquisition, followed by image processing and automatic 2D
classiﬁcation, rendered a total of 710,000 particles. This extensive
dataset displays certain morphological heterogeneity, with
particles that look like broken or deformed versions of those
highlighted in Fig. 3c and observed by negative staining
(Supplementary Fig. 8). Such heterogeneity arises from the highly
dynamic equilibrium for assembly, which includes single
hexamers (Fig. 3b and Supplementary Fig. 6) in addition to
debris from the inevitable equilibrium perturbation that takes
place during cryo-EM sample preparation. Nevertheless, the most
populated classes represent different views of a double-ring with
D6 symmetry (Fig. 3c, right). A total of 115,000 particles
associated with these classes were subjected to multiple rounds
of 3D classiﬁcation imposing D6 symmetry, 3D reﬁnement, and
post-processing to render a ﬁnal 3D reconstruction of the toroidal
particles (Fig. 3d). The 3D structure, obtained at a resolution of
8.55 Å (Supplementary Fig. 9), represents an ~65 Å wide and an
~55 Å high toroidal particle with a channel of ~15 Å in diameter.
The resolution is not high enough to determine individual
secondary structure elements, but it does resolve the monomers
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Fig. 3 Formation of toroidal hexameric–dodecameric assemblies in
solution. a Size-exclusion chromatography of CI2eng. The chromatogram
shows one peak corresponding to the monomer (M) and a broader peak for
the mixture of hexamer (H) and dodecamer (H2). b Analytical
ultracentrifugation of CI2eng resolving the three species: monomer (M),
hexamer (H), and dodecamer (H2). c (Left) cryo-image of CI2eng in
solution. Arrows point to end-on views and arrowheads to tilted views of
the particles. (Right) gallery of representative 2D classes classiﬁed with
Relion68. Doughnut shapes represent end-on views and the other shapes
various side views of the CI2eng assembly. d 3D reconstruction at sub-nm
resolution of the CI2eng assembly formed in solution.
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and their orientation based on their sole α-helix. The cryo-EM
structure reveals tight contacts between adjacent monomers in
each ring. The two rings are placed head to head and staggered,
have an ~5 Å gap between them, and interact through weak
contacts. We can thus conclude that CI2eng self-assembles in
solution onto D6 toroidal structures that replicate the wild-type
crystalline arrangement.
Assembly involves a fold-switch transition in the monomer.
The thermodynamic scheme of Fig. 1 requires a conformational
switch as driver of assembly. Two early pieces of evidence point to
the occurrence of a conformational switch on CI2eng upon
assembly. The ﬁrst evidence comes from the cryo-EM 3D
reconstruction, which shows that the monomer density is too
narrow to accommodate the entire native β-sheet (Fig. 4a). The
second evidence comes from thermal denaturation experiments.
If the assembly were composed of native monomers, raising the
protein concentration should stabilize the native structure, as it
generally happens in the denaturation of oligomeric proteins48.
However, we observe a strong destabilization of the CI2eng native
fold upon increasing protein concentration, whether monitored
by ﬂuorescence (Fig. 4b) or far-ultraviolet (UV) circular dichro-
ism (CD) (Supplementary Fig. 10), whereas the thermal unfolding
of CI2 is concentration insensitive, as expected for a monomeric
protein. The thermodynamic behavior of CI2eng strongly suggests
that the assembly process involves a switch from the native to an
alternate conformation.
Although thermal denaturation experiments by tryptophan
ﬂuorescence (Fig. 4b) and the far-UV CD signal at 222 nm
(Supplementary Fig. 10) show what appears to be a single
transition, analysis of the far-UV CD spectra as a function of
temperature reveals a double transition that is most apparent at
217 nm (Supplementary Fig. 11). CD spectra from the three
plateau regions (roughly corresponding to the three observed
species) are shown in Fig. 4c. As in CI2, the native spectrum (N in
Fig. 4c) of CI2eng is dominated by the contribution from the
tertiary environment of the sole tryptophan (W7). The spectrum
from the intermediate plateau indicates that the alternate
conformation that forms upon assembly is highly structured,
containing a mix of α-helix and β-sheet, but missing the
asymmetric tertiary environment around W7 (FS in Fig. 4c).
Finally, the spectrum at high temperature represents the
thermally unfolded monomer (U in Fig. 4c). The difference
spectra (N-FS and FS-U) reveal that the ﬁrst transition involves
breaking the tertiary environment of W7, in agreement with the
loss of the entire ﬂuorescence signal, whereas the second
transition involves melting of the β-sheet to produce an unfolded
state with residual α-helix content (Fig. 4d).
To investigate in situ the conformational switch coupled to
assembly that takes place at intermediate temperatures and/or
higher protein concentration, we employed solution NMR. The
CI2eng assemblies are expected to be invisible to conventional
NMR detection due to extreme spectral line broadening caused by
the slow tumbling rates associated to their size49. NMR should
thus only show the signals of the CI2eng monomer population,
which folds into the same native structure of CI2 (Fig. 2f).
Interestingly, NMR spectra obtained in conditions at which
CI2eng is about 85% assembled (Fig. 4e) show all the signals
corresponding to the small population of native monomer that
remains in solution (blue), but also show nine extra cross-peaks
with about six-fold higher intensity (red). The relative intensity of
the extra cross-peaks versus that of the ones corresponding to the
native monomer changes with protein concentration in the same
manner than the assembly-monomer ratio does (Supplementary
Fig. 12), thereby conﬁrming that the extra cross-peaks belong to
the assembled monomer. Sequential assignment indicates that
these signals are from the C-terminal segment of the protein: last
β-strand and end of the prior loop. Their 1H chemical shift values
cluster within the 8–8.5 p.p.m. range, in contrast to the large
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spread that the same signals experience in the native monomer
(Fig. 4e), thus indicating that they correspond to an unstructured
and ﬂexible segment. From these observations, we can conclude
that the alternate conformation that is formed upon assembly
results in the disordering of the C-terminal segment of CI2eng,
which becomes visible by NMR due to its enhanced conforma-
tional dynamics. This key result demonstrates that forming the
assembly involves a conformational transition of the monomer, as
per the thermodynamic scheme of Fig. 1. The conformational
change disrupts the tertiary environment around W7, which
renders it monitorable by ﬂuorescence and CD signals (Fig. 4a,
Supplementary Figs. 10 and 11). The structural change involves a
few residues, but it requires a drastic reorganization of the
monomer’s fold because the C-terminal strand is central within
the native β-sheet and hydrophobic core (see Fig. 2a).
To further characterize the structural reorganization of the
assembled monomer, we performed all atom molecular
dynamics (MD) simulations. As starting point for the simula-
tions, we built a structural model in which the C-terminal
strand is detached from the core (Fig. 5a, cyan), and, as negative
control, a model with the N-terminal strand unraveled (Fig. 5b,
light green). In the control simulations, we observed the quick
reconﬁguration of the N-strand that snaps back to reform the
native CI2 fold (Fig. 5b, dark green). Unraveling of the C-
terminal strand, however, triggers a large reorganization in
which the N-terminal strand grows longer and joins strands
2–3 to form a stable parallel β-sheet, whereas the C-terminal
tail remains free and unstructured (Fig. 5a, dark blue). Both
transitions occurred consistently in several trajectories (Fig. 5a,
b), indicating that the results are statistically robust (see
Methods). We thus take the average ﬁnal structure from the
C-terminal MD simulations (dark blue in Fig. 5a) as structural
model of the assembled CI2eng monomer. This structure
represents a true fold switch in which the native antiparallel
topology of CI2 is transformed onto a three-stranded, all-
parallel elementary Rossmann fold.
Atomic-resolution structural model of the assembly. We gen-
erated a structural model of the toroidal assembly at atomic
resolution based on the CI2eng fold-switched conformation. We
started by ﬁtting the fold-switched structure to the electron
density obtained by segmentation of the cryo-EM 3D recon-
struction (Fig. 6a). This ﬁt scores much better than the best ﬁt to
the native fold because the more slender three-stranded sheet of
the fold-switched conformation does ﬁt well within the density:
root mean square density (RMSD) in Rosetta of −3.42 versus the
−3.15Edens/res we obtained for the best ﬁt to the native structure
(Fig. 4a). We then generated a symmetric dodecamer of fold-
switched monomers and ﬁtted it to the density of the entire
particle by allowing Cartesian and angular rigid body reorienta-
tions of the monomers (see Methods). The resulting atomic-
resolution model of the toroidal assembly is shown in Fig. 6b.
Notably, this structure solves the last piece of the mechanistic
puzzle, namely, how the fold-switch transition stabilizes the
assembly. Since the CI2eng alternate fold is metastable, to effec-
tively compete with the more stable native fold, it must introduce
strongly stabilizing inter-monomer interactions upon forming the
assembly. The structural model of assembly does indeed reveal a
highly optimized inter-monomer interface (Fig. 6c). The alternate
fold exposes a new patch of hydrophobic surface that enables a
large contact interface between the elongated ﬁrst strand (W7,
L10 and V11) of one monomer and residues from the opposite
edge (L23, I31, V33, L56) of the adjacent monomer (Fig. 6c, left).
In addition, the structural model reveals a tight network of inter-
monomer salt bridges that provides additional stabilization to the
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Fig. 5 Structural model of the fold-switched CI2eng. aMD simulations of a structural model of CI2 in which its C-terminal strand has been unraveled using
Modeller. The initial model is shown on the left in cyan with both terminal strands highlighted in red. After multiple 1μs-long molecular dynamics
trajectories (center, in red, green and blue) the protein consistently transitions onto a fold-switch conformation that corresponds to a basic Rossman fold
(shown in blue on the right). b MD simulations of a structural model of CI2 in which its N-terminal strand has been unraveled using Modeller. The initial
model is shown on the left in light green with both terminal strands highlighted in magenta. After multiple 1-μs-long molecular dynamics trajectories
(center, in red, green and blue) the protein refolds back to its native structure, as shown in green on the right. For both a, b, RMSD was calculated versus
the initial structure (top subpanel) or the average of the three ﬁnal structures (bottom subpanel).
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rings, and speciﬁcity to lock the monomer–monomer orientation
within each ring (Fig. 6c, right).
Optimizing assembly via the fold-switched monomer. CI2eng
spontaneously forms toroidal assemblies, but it does so with
moderate propensity (Supplementary Fig. 7). As strategy for
optimizing the assembly and testing the mechanism, we decided
to ﬁne tune the stability of the switched fold. The switch involves
unwinding the C-terminal β-strand (Figs. 4e and 5) and breaking
the native interactions formed by its three hydrophobic residues.
Out of these three, the innermost residue (I59) stands out as key
stabilizer of the native fold (Fig. 7a, magenta). We tested the role
of I59 as native-fold gatekeeper on CI2eng by truncating its side
chain (replacement to Ala). As we expected, the I59A mutation
a b
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Fig. 6 Structure of the toroidal assembly of fold-switched monomers. a Three views of the fold-switched CI2eng structure ﬁtted to the electron density
corresponding to one monomer in the cryo-EM 3D reconstruction. b Top and side views of the atomic-resolution structural model of the double-ring
assembly of fold-switched CI2eng monomers (purple and yellow) ﬁtted into the cryo-EM volume (gray density). c Hydrophobic interface and salt-bridge
network between adjacent fold-switched monomers within each ring of the toroidal assembly.
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greatly enhanced the propensity to spontaneously form toroidal
assemblies (Fig. 7b). In fact, whereas CI2eng needs millimolar
concentrations to assemble at room temperature (blue), I59A-
CI2eng readily assembles in the micromolar range, becoming
nearly fully assembled at ~100 μM (magenta). Moreover, assem-
bly of I59A-CI2eng takes place via the same monomer fold
switching observed in CI2eng, as inferred from ﬂuorescence
and CD experiments (Supplementary Fig. 13). As further test, we
used an alternative approach based on excising the entire C-
terminal β-strand on the wild-type sequence (CI21–58, Fig. 7a,
green). CI21–58 exhibits a similarly enhanced propensity to
assemble (green). Our results on these two reengineered variants
conﬁrm the key role that the C-terminal β-strand plays in the
monomer fold switch. They also provide practical demonstration
of how to tune up the assembly process without targeting the
monomer–monomer interface.
Allosteric control of assembly. The fold-switching transition in
the monomer should permit to trigger or block the assembly
process in response to cues. To investigate this possibility, we
ﬁrst focused on temperature as effector. Since the enthalpy of
unfolding the metastable fold switch is much smaller than the
enthalpy of unfolding the native state, a moderate increase in
temperature should promote the monomer conversion from
native to alternate fold and thus enhance assembly. This
behavior is diagnostic because it is the exact opposite to con-
ventional temperature effects on protein assembly48. Using
differential scanning calorimetry (DSC), we could detect two
distinct, concentration-dependent transitions on CI2eng
(Fig. 7c). At the lowest concentrations only one transition is
observable, representing the thermal unfolding of the native
monomer in the absence of assembly (peak at ~337 K), as we
previously observed by ﬂuorescence (Fig. 4b) and CD (Sup-
plementary Fig. 10) experiments. At higher concentrations, the
DSC proﬁle splits into two peaks that move gradually apart as
protein concentration increases (Fig. 7c, e). These observations
are consistent with previous CD experiments (Supplementary
Figs. 10 and 11) and indicative of negatively coupled transi-
tions: one transition promoted and one hindered by protein
concentration (Fig. 7e). The early, concentration-promoted
transition involves the fold switch of the monomer followed by
assembly. The late transition corresponds to dissociation of the
assembly onto unfolded monomers. Experimental reruns
showed a reasonable degree of reversibility when the samples
were incubated for sufﬁciently long times (e.g., several hours) in
between runs (Supplementary Fig. 14), conﬁrming that the
process is under thermodynamic control. These experiments
demonstrate that moderate changes in temperature within the
physiologically relevant range can control assembly in a
reversible fashion. For example, at 0.6 mM and ~305 K, CI2eng
is mostly native and monomeric, but a 15° jump can trigger the
fold switch and achieve nearly complete oligomerization (dark
blue in Fig. 7c). The assembly optimized variants (I59A-CI2eng
and CI21–58) exhibit the same general features (Fig. 7d, e),
demonstrating that the allosteric switch is retained. The
quantitative differences among variants reveal the mechanistic
bases for their optimization of assembly (Fig. 7e). For instance,
the I59A mutation (magenta) promotes the monomer conver-
sion (lower T1) without affecting the stability of the assembled
particle (same T2). CI21–58 (green) promotes the fold switch
even more vigorously, but also makes a less stable assembly,
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Fig. 7 Optimization and allosteric control of assembly. a Promoting assembly by enhancing the fold-switch transition: (magenta) I59A mutation on
CI2eng, (green) 59–66 truncation on wild type. b Monomer fraction versus protein concentration for CI2eng (blue), I59A-CI2eng (magenta), and CI21–58
(green). c DSC thermograms of CI2eng at different protein concentrations. d As c for I59A-CI2eng. e Protein concentration versus position of exothermic
peaks from DSC (color as b). Data from c and d are indicated as larger circles of the same color shade. f Monomer recovery versus concentration of
C-peptide for CI21–58 at 80 μM. (Inset) distribution of CI21–58 monomer (M), hexamer (H), and dodecamer (H2) at 0mM (blue) and 4mM (red)
C-peptide, and at 4mM after dialysis (purple, star) obtained by analytical ultracentrifugation. In b, f, triangles represent analytical ultracentrifugation,
circles size-exclusion chromatography, and squares circular dichroism data.
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presumably owing to increased conformational ﬂexibility.
These compensatory effects result on similar net propensity to
assemble for the two optimized variants (Fig. 7b).
Temperature effects demonstrate the allosteric switch opera-
tion. However, practically, it is much more interesting to achieve
allosteric control by a molecule. We designed CI21–58 with this
goal in mind. The idea was to use a peptide containing the
truncated 59–66 region (sequence Ac-IAEVPRVG, see Methods),
which we term C-peptide, as external stabilizer of the native fold,
and thus as negative allosteric effector for assembly. In
experiments at very low protein concentration (2 μM), we ﬁnd
that the C-peptide does bind to the CI21–58 monomer and reverts
it to the native fold (Supplementary Fig. 15). More relevantly,
addition of the C-peptide to a pre-assembled 80 μM sample of
CI21–58 dissolves the assembled particles onto native monomers,
demonstrating its role as negative allosteric effector for assembly
(Fig. 7f). The inhibitory effect of the C-peptide on assembly is also
fully reversible (Fig. 7f, inset), conﬁrming this molecule is a bona
ﬁde allosteric effector. Finally, C-peptide and temperature
compete so that higher C-peptide concentrations are needed to
dissolve the more stable assemblies formed at moderately higher
temperatures (Fig. 7f, yellow). The two effectors together enable a
ﬁne external control of assembly.
Discussion
We have engineered an allosteric protein assembly using the
monomeric, two-state folding protein CI2 as scaffold. The tor-
oidal assemblies with D6 symmetry formed by our engineered
variants replicate the symmetry and stoichiometry of the wild-
type’s crystalline arrangement. What is special here is that we
drove assembly without targeting the inter-monomer interface of
the target complex. Our strategy was to promote a latent fold-
switch transition in the monomer. The switch involves the
unwinding of the C-terminal strand and the reorganization of the
remaining β-sheet onto an elementary, all-parallel Rossmann
fold. This metastable, alternate fold exposes a hydrophobic patch
that creates an inter-monomer interface to stabilize the complex.
Coupling between oligomerization and monomer fold switching
introduces allosteric control via the thermodynamic mechanism
shown in Fig. 1 (Fig. 8). In CI2, a protein evolved as a hyper-
stable protease inhibitor, the alternate fold is latent (only the U–N
equilibrium is observed, gray left arrow in Fig. 8). However, upon
engineering its sequence to accelerate the native unfolding rate,
the switched fold emerges and triggers assembly on cue
(blue top arrow). Because the alternate fold acts as gatekeeper, its
targeted stabilization—removing an extra key aliphatic side chain
(magenta top arrow) or just excising the last native β-strand
(green top arrow)—further promotes the assembly without
directly acting on the inter-monomer interface. External control
of assembly is exerted by temperature (positive effector) on all the
engineered variants, and by the C-peptide (negative allosteric
effector) on CI21–58 (top green).
Our results open a new research avenue towards the develop-
ment of allosteric macromolecular assemblies based on engi-
neering the conformational properties of the monomer. Recently
developed templated assembly strategies have led to the imple-
mentation of controllable assemblies of protein building blocks
that are able to respond to multiple cues19,20,29. In parallel, the
natural open-closed conformational transition of an ATP-driven
protein complex has been successfully reprogrammed to enable
light-induced control via an engineered photo-switchable cross-
link50. In this work, we combine both abilities by engineering a
fold-switch transition on the protein monomer, and effectively
coupling it to the formation of D6 toroidal assemblies in solution;
assemblies that are otherwise only found in the crystalline form.
The conformational transition acts as an allosteric switch that
responds to multiple, competing cues, such as temperature and
C-peptide. Control is also exerted at the functional level because
the only species with protease inhibitor activity is the native
monomer. There are many potential nanotechnological and
biomedical applications for such assemblies, including macro-
molecular on-demand drug delivery systems. For instance, the
operational principles we develop here could be used to engineer
biopharmaceutical target proteins that form non-functional
assemblies for in vivo storage, but are programmed to release
the biologically active monomers on demand.
A key step towards meeting those goals involves learning how
to engineer globular proteins to fold switch and exploit one of the
folds for assembly. The CI2 case makes a remarkable proof of
concept. Moreover, the emerging paradigm on protein fold
switching suggests that our strategy is likely generalizable.
Metamorphic proteins are a relatively recent discovery, but sev-
eral examples are now available of proteins that alternate between
folds42. Proteins speciﬁcally designed to switch folds have also
been achieved44,45. Recent computational analysis estimates that
up to 4% of the structural characterized proteins are actually
metamorphic43. Moreover, the coupling between fold switching
and assembly is widespread among naturally metamorphic pro-
teins, and often key for their biological function43. Our work
contributes to this new paradigm by shedding much needed light
onto the structural determinants of fold switching. CI2 folds into
a rare topology, unique to its family of protease inhibitors
(Supplementary Fig. 3). This topology induces structural strain
on the two protein termini to form the network of buried salt
bridges that locks the functional loop in its active conformation
(Fig. 2e)51. In contrast, the alternate fold represents the simplest
Rossmann motif (bab-b), one that is considered structural
ancestor of a large subclass of α/β parallel proteins40. We thus
propose that proteins with highly specialized native architectures
C-peptide SwitchN
H
H2
T [Protein]n
U
Fig. 8 A thermodynamic model of allosteric assembly via fold switching.
The scheme represents the thermodynamic model for allosteric assembly
of the engineered CI2 variants and its control via temperature and
concentration of C-peptide. All the engineered variants populate the same
ﬁve species: native monomer (N), fold-switched monomer (switch),
hexamer (H), dodecamer (H2) and unfolded monomer (U). The length of
the arrows represents the relative propensity for each step in the system.
Black and gray arrows represent equilibria that are common to all CI2
variants (not modiﬁed by our strategy). Colored arrows represent the
speciﬁc behavior of each engineered variant: (blue) CI2eng; (magenta)
I59A-CI2eng; (green) CI21–58. Each effector (temperature, protein
concentration and C-peptide) favors a speciﬁc step in the mechanism as
indicated in the Figure.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13686-1 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:5703 | https://doi.org/10.1038/s41467-019-13686-1 | www.nature.com/naturecommunications 9
maintain the primordial fold from which their architecture evo-
lutionary diverged in latent form. We know that those ancient
folds can accommodate vast sequence spaces, and thus, it is
reasonable to expect that such folds remain encoded as meta-
stable, or latent conformations in highly divergent sequences.
Methods
Cloning, expression, and puriﬁcation of CI2 variants. The amino-acid sequences
of wild-type CI2 and engineered versions (mutations shown in bold) are:
Wild-type CI2: MDLKTEWPELVGKSVEEAKKVILQDKPEAQIIVLPVGTIV
TMEYRIDRVRLFVDKLDNIAEVPRVG
CI2eng: MDAKTEWPELVGKSLEEAKKALLQDKPEATIIVIPVGTIVTMEYR
VDRVRIVVDKLDNIAEVPTVG
I59A-CI2eng: MDAKTEWPELVGKSLEEAKKALLQDKPEATIIVIPVGTIVT
MEYRVDRVRIVVDKLDNAAEVPTVG
CI21–58:MDLKTEWPELVGKSVEEAKKVILQDKPEAQIIVLPVGTIVTME
YRIDRVRLFVDKLDN
All proteins were synthesized using gene optimization (Top Gene Technologies
Inc.), cloned into the pBAT4 plasmid, and transformed in BL21-Gold(DE3)
Escherichia coli-competent cells (Agilent Technologies). LB medium with 100mg l−1
ampicillin was used to grow a cell culture at 37 °C to an OD600 of 1.2, at which time
expression of the protein was induced with isopropyl β-D-1-thiogalactopyranoside at
100mg l−1 overnight at 30 °C. Cells were harvested at 10,000 × g for 30min, lysed by
several freeze–thaw cycles, and centrifuged down at 60,000 × g for 60min. Protein
puriﬁcation was performed by high-performance liquid chromatography with an
anionic exchange column (HiTrap Q HP from GE Healthcare Life Sciences) in
20mM sodium borate buffer at pH 8.5 and a gradient of 0–1M NaCl. Fractions
containing the protein were pooled, dialyzed in the same buffer to remove salts, and
injected onto a reverse phase column (Proto 300 C4 column fromWestern Analytical
products) for a second puriﬁcation step. Fractions containing >99% pure CI2 variant
were pooled, conﬁrmed by mass spectrometry, and freeze dried.
Mutational strategy to promote the fold switch. The mutational strategy
aimed to: (1) destabilize the hyper-stable native fold of CI2; (2) accelerate the
unfolding rate; (3) increase the propensity of the protein to form its native sec-
ondary structure elements; and (4) reshufﬂe the hydrophobic interactions to
facilitate repacking on both conformations. A structural analysis of the CI2 native
fold and sequence analysis of the family of CI2 structural homologs (Supple-
mentary Fig. 3) led us to identify 10 target locations that were distributed over the
entire amino-acid sequence, included residues in each of secondary structure ele-
ments, were susceptible to enhancement of secondary structure propensity by
mutation, and/or were engaged in hydrophobic interactions determining the native
protein core (interactions between the β-sheet and either the α-helix or the func-
tional loop). Once the speciﬁc locations in the structure were identiﬁed, mutations
were designed to increase the secondary structure propensity according to the
semi-empirical propensity scales for β-sheet and α-helix as deﬁned in ref. 52, and to
reshufﬂe the hydrophobic packing of the native structure while: (1) keeping the
overall solvent accessible surface area constant; (2) minimizing the production of
cavities in the core; and (3) maintaining the overall hydrophobicity of the wild-type
sequence. The ﬁnal mutational strategy is summarized in Supplementary Table 2.
Equilibrium chemical and thermal denaturation experiments. Samples were
prepared dissolving the lyophilized protein in 7M GdmCl to eliminate any possible
non-speciﬁc aggregate induced by the freeze-dry procedure, and then dialyzed
extensively against 20 mM sodium borate at pH 8.5. For chemical denaturation
experiments, protein samples at 50 μM were prepared in solutions of GdmCl at
different concentrations in 20 mM sodium borate buffer at pH 8.5. The experi-
ments were performed at 298 K, and the unfolding reaction was monitored by
tryptophan ﬂuorescence. The chemical denaturation experiments (Fig. 2g in main
article) were ﬁtted to a two-state unfolding transition that rendered the following
parameters for wild-type CI2: Cm= 4.07M and ΔG0= 30.9 kJ mol−1; and for
CI2eng: Cm= 1.28 M and ΔG0= 10.9 kJ mol−1. For thermal denaturation experi-
ments, protein samples at different concentrations were prepared in 20 mM
sodium borate buffer at pH 8.5. Fluorescence experiments were performed col-
lecting the total ﬂuorescence emission after excitation at 280 nm in a Jobin Yvon
Fluorolog-3 spectroﬂuorometer from Horiba. Far-UV CD experiments were per-
formed measuring the molar ellipticity of the sample from 190 to 250 nm every
1 nm on a Chirascan CD spectrometer from Applied Photophysics.
Monomer recovery with C-peptide. The peptide corresponding to the C-terminal
segment of CI2 (Acetylated-IAEVPRVG) was synthesized using F-moc chemistry
and the purity conﬁrmed by mass spectrometry. A 10 mM stock solution was
prepared in 20 mM sodium borate buffer at pH 8.5. After preparation of the
protein samples at 80 μM (oligomerizing conditions) or at 2 μM (monomeric
conditions) and at different concentrations of the C-peptide, the mixtures were
maintained for a few hours at 298 K for equilibration before the measurements.
Monomer recovery was followed by analytical ultracentrifugation (using the con-
ditions indicated below) or by ﬂuorescence (using the conditions indicated above).
The ﬂuorescence signal was corrected for the effect of temperature on the tryp-
tophan ﬂuorescence measured in N-acetyl-tryptophanamide to permit direct
comparison of the experiments performed at 298 and 310 K.
Kinetic folding–unfolding experiments. Kinetic measurements of the
folding–unfolding relaxation of CI2 variants in response to changes in the con-
centration of chemical denaturant were performed at 298 K on a SX20-LED Stopped
Flow ﬂuorometer from Applied Photophysics. The lyophilized puriﬁed protein was
dissolved in 7M GdmCl and diluted to a ﬁnal protein concentration of 10 μM in
either a ﬁxed low or ﬁxed high ﬁnal concentration of GdmCl. Unfolding experi-
ments were performed by mixing the low GdmCl concentration sample with
solutions of GdmCl at different concentrations (prepared in 20 mM sodium borate
buffer at pH 8.5) at a 1:10 ratio. Refolding experiments were performed the same
way but using the high GdmCl concentration protein sample. Fluorescence emission
above 320 nm was collected with a long-pass ﬁlter after excitation at 280 nm. The
relaxation at each condition (ﬁnal concentration of GdmCl) was determined by
averaging 10 individual kinetic traces that showed no signs of mixing artefacts. The
resulting averaged traces were ﬁtted to a single exponential function (unfolding), or
to a single exponential plus a linear slope (refolding) to take into account the slow
proline isomerization process of these proteins. The relaxation rate as a function of
chemical denaturant (experiments in Fig. 1h in the main article) rendered the
following parameters: for wild-type CI2: kf0= 44 s−1, mf=−0.78 kJ mol−1 M−1
and ku0= 1.9 × 10–4 s−1, mu= 0.51 kJ mol−1 M−1; and for CI2eng: kf0= 25 s−1,
mf=−0.89 kJ mol−1 M−1 and ku0= 0.58 s−1, mu= 0.52 kJ mol−1 M−1.
Enzymatic activity measurements. The protease inhibitor activity of CI2 variants
was determined using a colorimetric assay for the conversion of N-benzoyl-L-
tyrosine ethyl ester (BTEE) to N-benzoyl-L-tyrosine catalyzed by the enzyme
chymotrypsin. Assays in the absence and presence of CI2 were performed fol-
lowing the protocol indicated by Sigma53. Different concentrations of BTEE (from
10 to 1000 μM) were mixed with 53 mM CaCl2, 200 nM CI2 variant (if needed),
and, ﬁnally, 53 nM chymotrypsin to a ﬁnal volume of 3 ml in 50 mM Tris buffer at
pH 7.8. After the addition of chymotrypsin, the sample was manually mixed and
introduced in a Cary 100 bio UV–Visible spectrophotometer from Varian to follow
the change in absorbance at 256 nm. The initial velocity of conversion is deter-
mined by ﬁtting the change in absorbance during the ﬁrst few seconds of the
reaction to a straight line. Initial velocities obtained for every different con-
centration of substrate were ﬁtted to the equation,
V0 ¼
VmaxS
Kappm þ S ; ð1Þ
where V0 is a vector with the measured initial velocities, Vmax corresponds to the
maximal velocity, S is a vector with the BTEE concentrations used in the assay, and
Kappm is the apparent Michaelis–Menten constant, which can be expressed as,
Kappm ¼ Km 1þ
I
Ki
 
; ð2Þ
where Km is the true Michaelis–Menten constant, I is the concentration of inhi-
bitor, and Ki is the inhibitor’s disocciation constant.
Analytical size-exclusion chromatography. Protein samples at different con-
centrations were prepared in 7M GdmCl and dialyzed against 20 mM sodium
borate at pH 8.5 to eliminate potential non-speciﬁc aggregates produced by the
freeze-dry procedure. For every run, 200 μl of sample were injected in a Superdex
200 Increase 10/300 GL size-exclusion column (from GE Healthcare). The chro-
matography run was performed using a ﬂow of 0.5 ml/min of a buffer solution with
20 mM sodium borate at pH 8.5 to separate the species with different
molecular mass.
Analytical ultracentrifugation. Sedimentation velocity (SV) measurements were
performed at 298 K and 48,000 r.p.m. (184,000 × g) using an Optima XL-I analy-
tical ultracentrifuge equipped with UV–VIS absorbance and Raleigh interference
optics (from Beckman Coulter). Samples of CI2 variants at different ﬁnal con-
centrations were prepared in 7M GdmCl, dialyzed against 20 mM sodium borate
buffer at pH 8.5, and ﬁltered before the experiment. Differential sedimentation
coefﬁcient distributions c(s) were calculated via least-squares boundary modeling of
SV data using SEDFIT54. From this analysis, the experimental sedimentation
coefﬁcients were corrected for solvent composition and temperature with the
program SEDNTERP55 to obtain the corresponding standard s values, s20,w. The
theoretical frictional ratio f/f0, a parameter related with the asymmetry of the
different protein species, was also calculated using SEDNTERP. The s20,w values
were correlated with theoretical s values for the cryo-EM 3D structures calculated
using HYDROMIC56.
Size-exclusion coupled to multi-angle light scattering. Size-exclusion chroma-
tography coupled to multi-angle laser light scattering measurements were carried
out in a DAWN-EOS multi-angle light scattering photometer equipped with an
Optilab rEX differential refractometer (from Wyatt Technology Corp) and a
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UV–VIS spectrophotometer SpectraSystem UV-2000 (from Thermo Scientiﬁc).
The instrument is conﬁgured to collect data in parallel from the incoming sample
ﬂow eluting (at 0.5 ml min−1 at 298 K) from a coupled Superdex 200 10/300 GL
size-exclusion column (from GE Healthcare). Samples of CI2 variants at 1 mM
prepared in buffer 20 mM sodium borate at pH 8.5 as described previously were
injected in the column (200 μl). A fraction of 200 μl from the size-exclusion
chromatography that contained mostly dodecamer was also reinjected. The
acquired raw data consisted of the scattering intensity at 14 scattering angles and
the concentration (differential refractive index or absorbance at 280 nm). The
average molecular masses for the species separated with the column were calculated
from the ratio of scattering to concentration using the ASTRA software57. Bovine
serum albumin (from Sigma-Aldrich) was used as standard to compute the cali-
bration constant.
Differential scanning calorimetry. Freeze-dried CI2 variants were dissolved in
7M GdmCl and then exhaustively dialyzed against 20 mM sodium borate buffer at
pH 8.5 to eliminate potential non-speciﬁc aggregates and allow the protein to
slowly requilibrate. DSC experiments were carried out on a MicroCal VP-Capillary
DSC (from Malvern Instruments). A typical calorimetric run involved a number of
buffer–buffer baselines to ensure proper equilibration of the calorimeter followed
by runs with the proteins under study with intervening buffer–buffer baselines, at a
scan rate of 200 K h−1. Several experiments were performed with protein con-
centrations in the 6–600 μM range. For wild-type CI2, absolute heat capacities were
calculated from the protein concentration dependence of the apparent heat capa-
cities58. The resulting proﬁle was analyzed according to the two-state equilibrium
model. The theoretical prediction for the absolute heat capacity of the native state
was also calculated. For the other CI2 variants, the absolute molar heat capacity
values at each protein concentration as a function of temperature were calculated
using subroutines provided by the Microcal software.
X-ray crystallography. Samples of wild-type CI2 were pooled and concentrated to
10mgml−1 in 20mM sodium borate buffer at pH 8.5 prior to crystallization
experiments. Crystallization screening was performed using the sitting drop vapor
diffusion method on a nano-dispensing robot HoneyBee (from Isogen) with com-
mercially available crystallization screens (Molecular Dimensions Wizard Classic
and Jena Bioscience Classic). Initial conditions were improved to grow ﬁnal dif-
fraction quality crystals at 293 K in 1.4M ammonium sulfate with 100mM Tris-HCl
at pH 8.5 (condition a) or in 25% PEG3350 with 100mM Tris-HCl at pH 8.5 and
200mM lithium sulfate (condition b). Obtained crystals were cryoprotected with a
solution containing 1M sodium malonate (condition a) or 30% ethylene glycol
(condition b) and ﬂash cooled by plunging them into liquid nitrogen. Diffraction
data were collected at 100 K at the Xaloc beamline of the ALBA synchrotron
(Barcelona, Spain) and integrated and scaled using MOSFLM59 and AIMLESS60.
Despite differences in crystallization conditions, both crystals belonged to the P622
space group with unit cell parameters of a= b= 68.77 and c= 50.56 Å (condition
a) or a= b=68.55 and c=53.10 Å (condition b), diffracting at 1.65 or 1.50 Å,
respectively. The Matthews value is 2.35 Å3/Da with a solvent content of 47.57% for
condition a and 2.45 Å3/Da with a solvent content of 49.76% for condition b. The
structures were determined by molecular replacement using MOLREP61, from the
CCP4 software suite with the crystal structure of wild-type CI2 (PDB code 2CI241)
as search probe. Initial rounds of reﬁnement were carried out using REFMAC62,
and ﬁnal TLS reﬁnement was done using PHENIX63. All model building, placement
of side chains, and water addition were performed using COOT64.
Cryo-electron microscopy. For cryo-EM sample preparation, Quantifoil grids
(R1.2/R1.3 300 mesh grids; ref. Q09684) were covered with a thin carbon layer
(4 nm). Aliquots (5 µl) of a 1 mM sample of CI2eng were incubated with the grid
(2–5 min), blotted, and plunged into a liquid ethane chamber. All operations were
performed on a Leica CPC manual plunger. Images were acquired in a FEI Talos
Arctica cryo-EM operated at 200 kV and equipped with a Falcon III detector, at a
calibrated magniﬁcation of ×120,000 (0.85 Å px−1 sample resolution), and a dose
rate of ~2.5 electrons Å−2. Exposures of 1.5 s were fractionated into 34 movie
frames. A total of 830 movies were recorded and subjected to movie correction
using MOTIONCORR65 and CTF correction with CTFFIND466. The EM suite
Scipion v1.267 was used for the subsequent image processing. A total of 710,000
individual particles were selected from the aligned micrographs and extracted. Four
rounds of image 2D classiﬁcation were performed using free-pattern maximum-
likelihood procedures (Relion 2D classiﬁcation)68 ending with 115,000 high-quality
particles. Representative 2D averages were used to generate several initial 3D
models with the software EMAN v2.1269. The particles were subjected to 3D
classiﬁcation using Relion and 77,750 particles were selected to continue several
rounds of classiﬁcation. D6 symmetry was imposed on the most consistent volume
and a 3D classiﬁcation with all 77,750 particles was performed with D6 symmetry
imposed. Particles were subjected to three more rounds of 3D classiﬁcation with
D6 symmetry, ending with 6200 high-quality particles, which were used for a ﬁnal
3D volume reﬁnement with D6 symmetry using Relion 3D auto-reﬁne followed by
a Relion post-processing step. The resolution was estimated with Fourier shell
correlation using 0.143 correlation coefﬁcient criteria69. Visualization of the 3D
models and docking of the atomic structures into EM volumes was performed
manually using USCF Chimera70.
Negative staining EM. Samples of CI2eng at a concentration of 1 mM were applied
to glow-discharged carbon grids and stained with 2% (w/v) uranyl acetate.
Micrographs were recorded in a JEOLJEM-1010 electron microscope, operated at
80 kV, with a TemCam F416 camera (from TVIPS GmbH) at 78,000 nominal
magniﬁcation to a ﬁnal 1.98 Å pixel−1 resolution. Individual particles were selected
automatically from micrographs and extracted with the XMIPP software package71.
Image classiﬁcation was performed using free-pattern maximum-likelihood pro-
cedures. Three hundred and ﬁfty-seven high-quality particles were selected to
perform 2D analysis. The particles were processed by angular reﬁnement techni-
ques implemented in EMAN without any imposed symmetry.
Nuclear magnetic resonance. Samples of uniformly 15N-13C-labeled CI2eng were
produced from bacterial culture using 13C6-D-glucose and 15NH4Cl (Spectra Stable
Isotopes) as sole carbon and nitrogen sources, respectively. The isotopically labeled
CI2eng was expressed and puriﬁed following the same protocol previously described
for the unlabeled protein. NMR samples for assignment were prepared at 1 mM
concentration of 15N-13C-labeled protein in 5% D2O/95% H2O at pH 7.0. NMR
data were acquired at 293 K or 308 K on a Bruker Avance III 600MHz spectrometer
equipped with a triple-resonance triaxial gradient probe. The following experiments
were acquired to perform the sequential backbone and side chain assignment: [1H-
15N]HSQC, HNCO, CCONH, HCCONH, HNCACB, CBCA(CO)NH, and
HBHACONH. All NMR experiments were processed with NMRPipe72 and ana-
lyzed with PIPP73 and Sparky74. In ﬁrst instance, sequential assignment of the
monomeric CI2eng signals was carried out using a standard set of multidimensional
heteronuclear triple-resonance NMR experiments (CCONH, HCCONH, and
HBHACONH), leading to complete backbone resonance assignments excluding the
four existing prolines. Once the assignment of the monomer signals was completed,
the remaining signals were tentatively identiﬁed as corresponding to the assembled
species. The identiﬁcation of the assembly signals was subsequently conﬁrmed from
the changes in intensity relative to the monomer signals observed in HSQC
experiments performed at various protein concentrations to alter the monomer-
assembly equilibrium (see Supplementary Fig. 12). The changes in relative inten-
sities were compared with independent data of the monomer assembly obtained by
size-exclusion chromatography and analytical ultracentrifugation (Fig. 3a, b, Sup-
plementary Figs. 6 and 7)). Once unambiguously identiﬁed as assembly signals, the
extra cross-peaks were assigned sequentially using the full suite of 3D experiments
and following the same strategy used for the native monomer.
MD simulations. Structural models of the CI2 monomer with either the C-terminal
or the N-terminal strands removed from the structure were generated starting from
the 2CI2.PDB ﬁle. The control structure with the open N terminus (with residues
N2 to G12 unraveled) and the target structure with the open C terminus (with
residues L56 to G66 unraveled) were generated using MODELLER. Missing atoms
were added and the protonation state of all charged residues was determined using
PDB2PQR v2.0 at pH 775. All atom MD simulations starting with both structures
were performed using the CHARMM22* force ﬁeld76 and the TIP3P water model,
which is compatible with the CHARMM force ﬁeld in Gromacs 5.0. The protein was
introduced in an octahedral box that was subsequently ﬁlled with water molecules.
The entire system was neutralized to achieve a net charge of zero and energy
minimized to reach a tolerance of 1000.0 kJ mol−1 nm−1 using the steepest descent
algorithm. All bonds were constrained using LINCS. Particle Mesh Ewald was used
for long-range electrostatics with periodic boundary conditions. A modiﬁed
Berendsen thermostat was used for the temperature coupling of the system. The
time step used in the simulations was 2 fs. The system was subjected to NVT
(constant number of particles, volume and temperature) equilibration for 100 ps
with the position of the protein restrained, followed by NPT (constant number of
particles, pressure and temperature) equilibration for another 100 ps. Finally, three
1-μs-long trajectories were produced in the NPT ensemble for each starting
structure. RMSD was calculated with g_rms, using the Cα atoms of the residues not
involved in the unraveling transition (residues 13 to 66 for the open N terminus
simulation and residues 2 to 55 for the open C terminus simulation).
Atomic-resolution structural model of the assembly. The structural model for
the fold-switched monomer obtained from the MD simulations (see previous
section) was ﬁtted into the density corresponding to a monomer in the 3D cryo-
EM volume using USCF Chimera70. The monomer density was generated by
segmentation of the density for the whole particle (double hexameric ring). Final
ﬁtting reﬁnement of the monomer structure into the electron density was done
using the RosettaCommons software with the relax in electron density protocol
developed by DiMaio et al. 77. The talaris2014 energy function was used to score
the structure and ﬁtting to the electron density. The best-ﬁtted monomer model
generated in the previous step was aligned in the dodecamer density and used to
generate the 12 monomers of the entire particle using the relax in density protocol
and non-crystallographic 2_6 symmetry78. The symmetry deﬁnition ﬁle (generated
via de make symmdef ﬁle.pl script) was modiﬁed to allow cartesian and angular
rigid body orientations of the monomers during dodecamer ﬁtting. The protocol
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involves setting up the symmetry, optimizing the symmetric packing of rotamers
(allowing extra chi rotamer sampling), symmetric energy minimization, and ﬁtting
into the electron density. The same energy function (talaris2014) was used in this
step and several thousand structures were generated with different weights for the
electron density. The lowest scoring energy structure was chosen as atomic-
resolution structural model of the toroidal dodecameric assembly.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data included in the ﬁgures and supporting the ﬁndings of this study are available
from the corresponding author upon reasonable request. The atomic coordinates for the
structures of the classical geometry and the domain-swapped geometry have been
deposited in the Protein Data Bank under the ID codes 6QIY and 6QIZ, respectively. The
electron density map obtained from cryo-EM has been deposited in the Electron
Microscopy Data Bank under the ID code EMD-4568.
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